Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Beijing YiCheng Bioelectronics Lands $10.3 Million in Series A Funding

publication date: Apr 13, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Beijing YiCheng Bioelectronics Technology Co. Ltd., China’s leading manufacturer of OTC blood glucose monitoring devices, closed a $10.3 million Series A funding, raising money from Sequoia Capital and PreIPO Capital. Sequoia Capital China runs a $1 billion fund, and PreIPO Capital has been involved in China private equity and venture capital investing since 1999. More details...

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...